Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shortened Steroid Therapy in Moderate and Severe PCP in HIV/AIDS
NCT03856229Enrolling by invitation
- Sponsor
- Centro de Investigación en Enfermedades Infecciosas
- Start
- Mar 2019
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of prednisone in Pneumocystis jirovecii pneumonia (PJP) (2 arms), sponsored by Centro de Investigación en Enfermedades Infecciosas. Primary endpoint: Cumulative incidence of Mortality at 30 days. Started Mar 2019; status: enrolling by invitation.
02
Drugs
prednisone
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT03856229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03856229.